CINECA IRIS Institutional Research Information System

Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol

Fagioli, F.;
2017-01-01
2017
PHARMACOGENOMICS JOURNAL
17
1
4
10
http://www.nature.com/tpj/
Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clinical Trials as Topic; Consolidation Chemotherapy; Female; Gastrointestinal Diseases; Gene Deletion; Genetic Predisposition to Disease; Glutathione Transferase; Humans; Induction Chemotherapy; Infant; Logistic Models; Male; Multidrug Resistance-Associated Proteins; Multiplex Polymerase Chain Reaction; Mutation; Nervous System Diseases; Pharmacogenetics; Pharmacogenomic Testing; Phenotype; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Pyrophosphatases; Receptor, Adenosine A2A; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Pharmacogenomic Variants; Molecular Medicine; Genetics; Pharmacology
Franca, R.*; Rebora, P.; Bertorello, N.; Fagioli, F.; Conter, V.; Biondi, A.; Colombini, A.; Micalizzi, C.; Zecca, M.; Parasole, R.; Petruzziello, F.; Basso, G.; Putti, M.C.; Locatelli, F.; D'Adamo, P.; Valsecchi, M.G.; Decorti, G.; Rabusin, M.
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
tpj.2015.83.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 493.38 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
493.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1690473
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact